THESEUS PHARMACEUTICALS, INC. Accumulated Other Comprehensive Income
THESEUS PHARMACEUTICALS, INC. had Accumulated Other Comprehensive Income of -$345.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2023-11-17
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$345.00K.
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$561.00K.
- 2023-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$159.00K.
- 2022-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$386.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2023-09-30 | -$345.00K 10-Q · filed 2023-11-17 |
| 2023-06-30 | -$561.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$159.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$386.00K 10-Q · filed 2023-11-17 |
| 2022-09-30 | -$550.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$332.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$129.00K 10-Q · filed 2022-05-12 |